Haemonetics Corporation (HAE) valuation · rev $1.33B
Haemonetics Corporation (HAE) rev $1.33B.
| Metric | Value |
|---|---|
| Market cap | $3.24B |
| Revenue | $1.33B |
| P/S | 2.4 |
HAE valuation FAQ
What is HAE's market cap?
Haemonetics Corporation (HAE) market cap is $3.24B on the latest cached fundamentals snapshot.
What is HAE's latest revenue?
Latest cached Haemonetics Corporation (HAE) revenue was $1.33B. Statements: https://lician.com/financials/hae
What is HAE's price-to-sales ratio?
Haemonetics Corporation (HAE) price-to-sales (P/S) is 2.4, cached market cap $3.24B divided by revenue $1.33B.
How many HAE valuation scalars are listed on this page?
This page lists 3 cached valuation scalars for Haemonetics Corporation (HAE): Market cap, Revenue, and P/S.
Where is HAE valuation listed?
Cached valuation multiples for Haemonetics Corporation (HAE) are listed at https://lician.com/valuation/hae.
Not investment advice. Cached rows, not a live tape.